| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/10/2004 | US20040109841 absence of a linker minimizes structural complexity of the derivative and simplifies synthesis of the derivative |
| 06/10/2004 | CA2506820A1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/09/2004 | EP1425404A2 Vaccinia virus mva-e3l-knockout-mutants and use thereof |
| 06/09/2004 | EP1425380A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 06/09/2004 | EP1425305A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 06/09/2004 | EP1425298A2 Subunit respiratory syncytial virus vaccine preparation |
| 06/09/2004 | EP1424897A2 Compositions and methods for treatment of cancer |
| 06/09/2004 | EP0773991B1 Active calpain expressed by baculovirus |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | CN1502368A Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 06/09/2004 | CN1502367A Immunoprophyaxis nose drops and preparation process thereof |
| 06/08/2004 | US6747007 Cationic, polyphemusin-like peptides |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746860 Paramyxovirus vectors used for transfer of foreign genes |
| 06/03/2004 | WO2004046319A2 Bacteriophage having modified holin and uses thereof |
| 06/03/2004 | WO2004045645A2 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide |
| 06/03/2004 | WO2004045529A2 West nile virus vaccine |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004021781A3 Cryptophlebia leucotreta granulovirus (crlegv-sa) as a biological control agent |
| 06/03/2004 | WO2004013277A3 Large circular sense molecule array |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | WO2003018820A3 Mutant recombinant adeno-associated viruses related applications |
| 06/03/2004 | US20040106194 Genetically engineered gene transfer vector comprising mutiple viral serotype sequences and E4 region of preferential virus for use as transfer tool in gene therapy and vaccine preparation |
| 06/03/2004 | US20040106184 Chromatographic methods for adenovirus purification |
| 06/03/2004 | US20040106136 Method for testing drug susceptibility of HIV |
| 06/03/2004 | US20040106103 Novel retrovirus associated with myelodysplastic syndromers and uses thereof |
| 06/03/2004 | US20040106100 Dna vaccines encoding hiv accessory proteins |
| 06/03/2004 | US20040105845 Delivering a genetic sequence to cells for gene therapy |
| 06/03/2004 | US20040105844 transfecting herpes simplex virus host cells with ampliicons by genetic engineering packaging a signal and expression vectors |
| 06/03/2004 | CA2504331A1 Bacteriophage having modified holin and uses thereof |
| 06/02/2004 | EP1424390A1 The intact hepatitis c virus and the method for culturing it in a vitro cell culture |
| 06/02/2004 | EP1423543A2 Detection of bovine viral diarrhea virus in tissue samples |
| 06/02/2004 | EP1423525A1 Recombinant mva capable of expressing structural hcv antigens |
| 06/02/2004 | EP1423522A2 Hepatitis c virus replicons and replicon enhanced cells |
| 06/02/2004 | EP0870058B1 Use of nucleic acids obtained from the sequence of swine retrovirus |
| 06/02/2004 | CN1500866A Large brill rhabdo virus toxic strain and its preparation method and application |
| 06/02/2004 | CN1500865A Lefteye flounder lymph tumour virus toxic strain, its preparation method and application |
| 06/02/2004 | CN1500864A Mandarin fish rhabdo virus toxic strain, its preparation method and application |
| 06/02/2004 | CN1152138C Glandular related viral vector and preparing method and use thereof |
| 06/01/2004 | US6743631 Non-primate mammalian cell lines having no endogenous retroviral sequences for packaging; envelope proteins; gag/pol genes |
| 06/01/2004 | US6743620 Comprises transgenic gag/pol gene expression systems; recombinases; antibiotic resistance; envelope proteins; vesicular stomatitis virus g-protein |
| 05/27/2004 | WO2004044182A2 Highly permissive cell lines for hepatitis c virus replication |
| 05/27/2004 | WO2004044004A2 T cell receptor display |
| 05/27/2004 | WO2004035616A3 Adenovirus expressing genes in reverse order and use thereof |
| 05/27/2004 | WO2004033696A3 Recombinant adenoviral vectors and applications thereof |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004001051A3 Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102372 Therapeutic antiangiogenic compositions and methods |
| 05/27/2004 | US20040101965 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/27/2004 | US20040101929 Comprises transgenic yellow grouper brain cell expressing immunoglobulin complex which prevents viral infection in teleost farms; animal husbandry and veterinary medicine |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101514 High transgene expression of a pseudotyped adeno-associated virus type |
| 05/27/2004 | CA2813515A1 T cell receptor display |
| 05/27/2004 | CA2505558A1 T cell receptor display |
| 05/27/2004 | CA2505551A1 Highly permissive cell lines for hepatitis c virus replication |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421185A2 Rapid cryobaric sterilization and vaccine preparation |
| 05/26/2004 | EP1421184A2 Live attenuated strains of prrs virus |
| 05/26/2004 | EP1420822A2 Modified vaccinia virus ankara for the vaccination of neonates |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420819A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 05/26/2004 | CN1498963A Method for producing virus like granules of human papilloma virus |
| 05/26/2004 | CN1151250C Recombinant adenovirus for preventing baby's diarrhea |
| 05/25/2004 | US6740740 Process for isolating and purifying proteins and peptides from plant sources |
| 05/25/2004 | US6740524 A phage expressing a bi-functional protein with a nuclear translocation and cell adhesion activities; used to package a foreign substance such as a gene, and in gene therapy |
| 05/25/2004 | US6740519 A signal transducer and activator of transcription that is phosphorylated when cells are treated with interferons, leads to induction of specific gene expression which results in an antiviral stage and other biological responses |
| 05/25/2004 | US6740515 Recombinant adenovirus |
| 05/25/2004 | US6740511 Comprising mutations at one or more residues within the region of fiber stretching; used in gene therapy |
| 05/25/2004 | US6740492 High sensitivity phage display biomolecule detection |
| 05/25/2004 | US6740490 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with cd antigens; animal husbandry |
| 05/25/2004 | US6740324 Modified cytomegalovirus, the modifications include adding heterologus sequence enconding a non-viral chemokine element and/or immunogenic polypeptide, and/or diabling a viral dissemination gene |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/21/2004 | WO2004042042A1 Vaccines against west nile virus |
| 05/21/2004 | WO2004042031A2 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 05/21/2004 | WO2004042025A2 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 05/21/2004 | WO2004042001A2 Virus-like particles, methods of preparation, and immonogenic compositions |
| 05/21/2004 | WO2004040976A1 Cryogenically protected viral delivery systems and related manufacture and use |
| 05/21/2004 | WO2004040973A2 Organellar targeting of rna and its use in the interruption of environmental gene flow |
| 05/21/2004 | WO2004024867A3 Vigilant vector system |
| 05/21/2004 | WO2004018685A3 Active fusion proteins and method for the production thereof |
| 05/21/2004 | WO2004003153A9 Live replicating spumavirus vector |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003050275A8 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/21/2004 | WO2003049766A8 Method of purifying hepatitis a virus particles and vaccine preparation |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040096972 Chimeric plasmid comprising a replicative retroviral genome, and uses |
| 05/20/2004 | US20040096850 For decreasing the phosphorus waste derived from monogastric animal nutrition; feeds |
| 05/20/2004 | US20040096823 Virion-based fusion assay |
| 05/20/2004 | US20040096463 Influenza antigen preparation obtainable by the following process, in the manufacture of an intradermal flu vaccine: (i) harvesting of virus-containing material from a culture; (ii) clarification of the harvested material to remove |
| 05/20/2004 | US20040096460 Attenuated forms of the virus produced by mutating specific regions of the viral genome. The virus and mutated forms of the virus may be used to induce the production of antibodies to FIV-141, and in vaccines designed to protect cats from FIV, |
| 05/20/2004 | US20040096458 Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo |
| 05/19/2004 | EP1420065A1 Process for producing inactivated virus envelope |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | CN1150322C Low-virulent vaccine K genom sequence of tomato mosaic and use |